- Biotech on the Web - https://biotechontheweb.com -

Canopy Growth Sues GW Pharma for Using Their Patent

Posted By On In Biotech (General),Contract Manufacturing,Epilepsy | Comments Disabled
Share:
[1] [2] [3] [4]

Most of us immediately think of cannabis oil when we see the CBD- and THC-rich super sticky sludge usually found in vaporizer cartridges. Yet, do you have any idea of how it’s all made?

Well, one of the most popular manufacturing processes — the CO2 method — uses carbon dioxide to extract the required components of the plant.

However, Canopy Growth, one of the biggest cannabis producers in Canada, claims [5] they hold the right to this technology.

Namely, just recently, the company received a US patent. And now, anyone caught using their technology potentially owes them money.

MORE…

Author: Canan Schuman, PharmD/PhD [6]

Canan Schumann is Chief Editor for Axxiem and for Axxiem's blog "BiotechOntheWeb". When not writing for Axxiem, Canan works as a Clinical Research Scientist II at the Research and Development Department at Molecular Testing Labs, developing endpoint assays for the detection of infectious disease and cancer. Canan currently resides in Portland, Oregon, where he received his Honors Bachelor of Science (HBS), Doctor of Pharmacy (PharmD.), and his Doctor of Philosophy (Ph.D.) in Biopharmaceutics at Oregon State University.